A deeper look at unmanaged AI use, also known as "shadow AI", as a response to workflow friction in laboratories.

Today, health plans are shifting dollars to more value-based contracts along with investments in population health management. Digitizing lab results across all care settings and unlocking the ...

This article explores the lab AI maturity curve in biopharma R&D, from passive ELNs to active AI-powered systems that ...